ChemoCentryx, Inc. ( CCXI) - Stock Earnings

CCXI Quarterly earnings

DateEarningsRevenue
2021Q4 -40.5 million USD 2.3 million USD
2022Q1 -38.6 million USD 5.5 million USD
2022Q2 -31.7 million USD 11.8 million USD

CCXI Yearly earnings

DateEarningsRevenue
2019 -55.5 million USD 36.1 million USD
2020 -55.4 million USD 64.9 million USD
2021 -131.8 million USD 32.2 million USD

CCXI

Price: $51.99

52 week price:
14.95
52.00

Earnings Per Share: -0.66 USD

P/E Ratio: -91.33

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 2.0 million

Ebitda: -6.8 million

Market Capitalization: 3.7 billion

Links: